Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of James Holm as Chief...
Australian medicinal cannabis company Cronos Australia (ASX: CAU) has started trading on the Australian Securities Exchange, following a successful AUD$20 million initial public offering (IPO) of shares....
On the first anniversary of Canadian cannabis legalization, “Legalization 2.0” or “Cannabis 2.0” will allow popular cannabis derivatives like edibles, infused beverages, and vapes to legally...